Dog Immune-Mediated Hemolytic Anemia

Immune-mediated hemolytic anemia is a serious autoimmune disease in dogs where the immune system destroys its own red blood cells, requiring urgent treatment.

Key Facts

IMHA is the most common acquired hemolytic anemia in dogs
The immune system produces antibodies that target and destroy red blood cells
Cocker Spaniels, Poodles, and Old English Sheepdogs are predisposed breeds
Signs include pale or yellow gums, extreme weakness, rapid breathing, and collapse
Emergency blood transfusions may be needed to stabilize critically ill dogs
Immunosuppressive drugs including prednisone form the core of treatment
Thromboembolism is a major complication killing many otherwise treatable dogs
Relapse rates reach 30-40% even after successful initial treatment

Welfare Considerations

IMHA is a terrifying disease for affected dogs, causing rapid collapse from oxygen deprivation as red blood cells are destroyed. Dogs experience profound weakness, breathlessness, and confusion. Treatment with high-dose steroids causes its own side effects including excessive hunger, thirst, and behavioral changes. The risk of blood clots adds another life-threatening dimension. Even successful cases require months of careful monitoring, creating prolonged stress.

What You Can Do

Recognize the emergency signs of IMHA - seek veterinary care immediately for sudden weakness and pale gums
Ask your vet about thromboembolism prevention during IMHA treatment
Support canine autoimmune disease research
Keep detailed medical records for dogs who have had IMHA
Consider pet insurance for breeds predisposed to autoimmune conditions